SCHEMBL4498207

SCHEMBL4498207

Cc1scc2c1c(O)c(C(=O)N(C)c1cc(F)ccc1F)c(=O)n2C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
PGR P06401 1/20 0.39
HIF1A Q16665 5/20 0.35
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
HTR7 P34969 1/20 0.35
HTR6 P50406 1/20 0.35
HTT P42858 1/20 0.32
HSD17B1 P14061 2/20 0.32
HSD17B2 P37059 2/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TRPA1 O75762 1/20 0.30
TRPV4 Q9HBA0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4494240 0.92 HDAC4 (0.39) HDAC4MEN1KMT2APGRHIF1A
SCHEMBL4505852 0.84 ERCC5 (0.37) HDAC4MEN1KMT2APGRHIF1A
SCHEMBL4508104 0.81 MEN1 (0.45) HDAC4MEN1KMT2APGRHIF1A
SCHEMBL7201251 0.80 HDAC4 (0.48) HDAC4MEN1KMT2APGRHIF1A
SCHEMBL5164306 0.80 HDAC4 (0.48) HDAC4MEN1KMT2APGRHIF1A
SCHEMBL4504478 0.79 MEN1 (0.52) HDAC4MEN1KMT2APGRHSD17B1
SCHEMBL4496044 0.79 MEN1 (0.49) HDAC4MEN1KMT2APGRKDM4E
SCHEMBL5163897 0.79 HDAC4 (0.64) HDAC4MEN1KMT2APGRHIF1A
SCHEMBL4510892 0.78 KMT2A (0.63) HDAC4MEN1KMT2APGRHIF1A
SCHEMBL7614121 0.78 HDAC4 (0.46) HDAC4MEN1KMT2APGRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553849-B2 Compounds ACTIVE BIOTECH AB (SE) 2009-06-30 US disclosed
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP disclosed
EP-1776369-A1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE Active Biotech AB (SE) 2007-04-25 EP disclosed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US disclosed
WO-2005123744-A1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004038-A1 Novel compounds REL, CLIC4, C5 HDAC4 424/4885MEN1 509/4885KMT2A 4071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.